Unexpected insights for anti-EGFR cancer therapy

被引：2
|
作者：
Depeille, Philippe [1 ]
Warren, Robert S. [1 ]
Roose, Jeroen P. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
来源：
ONCOTARGET | 2015年 / 6卷 / 22期
关键词：
Chromosome Section; colorectal cancer; therapy; Ras; EGFR; METASTATIC COLORECTAL-CANCER; MUTATIONS; CETUXIMAB; IRINOTECAN; GROWTH;
D O I：
10.18632/oncotarget.5115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18746 / 18747
页数：2
相关论文
共 50 条
  • [1] Anti-EGFR therapy in first-line colorectal cancer
    Lamas, Maria J.
    Duran, Goretti
    Gallardo, Elena
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1499 - 1503
  • [2] Optimizing Anti-EGFR Strategies in Cancer Treatment
    Toschi, Luca
    Finocchiaro, Giovanna
    Garassino, Isabella
    De Vincenzo, Fabio
    Campagnoli, Elisabetta
    Ceresoli, Giovanni Luca
    Cavina, Raffaele
    Zucali, Paolo Andrea
    Santoro, Armando
    Cappuzzo, Federico
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 267 - 275
  • [3] Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies
    Lievre, Astrid
    Laurent-Puig, Pierre
    PERSONALIZED MEDICINE, 2009, 6 (02) : 145 - 157
  • [4] A blood biomarker for monitoring response to anti-EGFR therapy
    Hughes, Nicholas P.
    Xu, Lingyun
    Nielsen, Carsten H.
    Chang, Edwin
    Hori, Sharon S.
    Natarajan, Arutselvan
    Lee, Samantha
    Kjaer, Andreas
    Kani, Kian
    Wang, Shan X.
    Mallick, Parag
    Gambhir, Sanjiv Sam
    CANCER BIOMARKERS, 2018, 22 (02) : 333 - 344
  • [5] Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories
    Lei Cheng
    Wei Ren
    Li Xie
    Ming Li
    Jiang Liu
    Jing Hu
    Bao-Rui Liu
    Xiao-Ping Qian
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1 - 13
  • [6] Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories
    Cheng, Lei
    Ren, Wei
    Xie, Li
    Li, Ming
    Liu, Jiang
    Hu, Jing
    Liu, Bao-Rui
    Qian, Xiao-Ping
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 1 - 13
  • [7] Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
    Li, Qing-Hai
    Wang, Ying-Zhao
    Tu, Jian
    Liu, Chu-Wei
    Yuan, Yu-Jie
    Lin, Run
    He, Wei-Ling
    Cai, Shi-Rong
    He, Yu-Long
    Ye, Jin-Ning
    GASTROENTEROLOGY REPORT, 2020, 8 (03): : 179 - 191
  • [8] Markers of resistance to anti-EGFR therapy in colorectal cancer
    Shaib, Walid
    Mahajan, Reena
    El-Rayes, Bassel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 308 - 318
  • [9] Anti-EGFR targeted therapy for squamos cell head and neck cancer
    Kawecki, Andrzej
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (05): : 264 - 271
  • [10] Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
    Meriggi, F.
    Di Biasi, B.
    Abeni, C.
    Zaniboni, A.
    CURRENT DRUG TARGETS, 2009, 10 (10) : 1033 - 1040
12345